#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Doctor in our hospital is using this intelligent system for accurate diagnosis

Doctor in our hospital is using this intelligent system for accurate diagnosis. (Photo: Business Wire)


March 31, 2020 — The Intelligent Evaluation System of chest computed tomography (CT) for COVID-19, developed by YITU under the guidance of Shanghai Public Health Clinical Center, was officially launched and was put into the first-line battle against COVID-19 pandemic on Jan. 28. It is the first AI-equipped diagnostic assistant, which significantly improves efficiency in identifying coronavirus through automatic detection and quantitative analysis within 2-3 seconds, and eases the burden of Chinese doctors.

YITU Healthcare reinforced its R&D capability with multi-departments cooperation right after the outbreak of the pandemic and released its cutting-edge AI diagnosis system, with upgrades on a daily basis during the Chinese New Year. YITU assisted many designated medical institutions and supported the frontline heroes fighting the pandemic.

According to its official public account of Shanghai Public Health Clinical Center, one of the authoritative institutions in the field of infectious diseases in China and the key unit for the treatment of COVID-19 in Shanghai, an article titled "AI Aids the Scientific Prevention and Control, Intelligent Evaluation System for COVID-19 Launched in Shanghai Public Health Clinical Center", announced its latest achievements in using artificial intelligence technology to help doctors carry out quantitative analysis and evaluation of therapeutic efficacy of new coronavirus lesions based on CT images.

COVID-19 Diagnosis and Treatment Plan (Trial Version 7) issued by the General Office of the National Health Commission of the People's Republic of China stipulates that CT imaging results should be used as one of the criteria for the diagnosis of COVID-19 nationwide. At the same time, based on clinical experience, the CT imaging performance of COVID-19 is further clarified and the quantitative evaluation of CT images is incorporated into the clinical classification basis.

YITU's AI-driven solution of intelligent diagnosis and quantitative evaluation of CT images of COVID-19, are through industry-leading image algorithms, and grade the severity of various pneumonia diseases of local lesions, diffuse lesions, and whole lung involvement. Furthermore, it accurately quantifies the cumulative pneumonia load of the disease through quantitative and omics analysis of key image features such as the morphology, range, and density of the lesion, and achieves a dynamic 4-D contrast of the lung lesions on the CT, helping in clinical judgment of the condition, evaluation of the efficacy, and prediction of the prognosis.

Taking up the challenge and responsibility in response to frontline needs and requests, YITU's Intelligent Evaluation System of Chest CT for COVID-19 has been adopted across 25 provinces and municipal autonomous prefectures in 100 medical institutions and served over 100,000 person-times in China by far.

For more information: www.yitutech.com

Related Coronavirus Content:

VIDEO: Use of Telemedicine in Medical Imaging During COVID-19

VIDEO: How China Leveraged Health IT to Combat COVID-19

 CDRH Issues Letter to Industry on COVID-19

Qure.ai Launches Solutions to Help Tackle COVID19 

ASRT Deploys COVID-19 Resources for Educational Programs

Study Looks at CT Findings of COVID-19 Through Recovery

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

The Cardiac Implications of Novel Coronavirus

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic

Emerging Technologies Proving Value in Chinese Coronavirus Fight

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)


Related Content

News | Digital Pathology

March 11, 2026 — Royal Philips has announced the expansion of its digital pathology portfolio with new cloud-enabled ...

Time March 26, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 25, 2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets ...

Time March 26, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
News | Cybersecurity

March 23, 2026 —Sacumen has launched ConnectX, a unified AI platform that gives cybersecurity product companies full ...

Time March 25, 2026
arrow
News | Radiology Imaging

March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...

Time March 23, 2026
arrow
News | Radiology Business

March 1, 2026 — A new study from the Harvey L. Neiman Health Policy Institute found that practice turnover (i.e ...

Time March 19, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 18, 2026 — GE HealthCare and Springbok Analytics have entered a development agreement that will aim to leverage ...

Time March 18, 2026
arrow
News | Radiology Education

March 17, 2026 – The Center for Radiology Education (CRE) has announced a nationwide initiative to provide scholarships* ...

Time March 17, 2026
arrow
News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Radiology Business

March 12, 2026 — DelveInsight's has released its latest Diagnostic Imaging Equipment Market Insights report. The in ...

Time March 13, 2026
arrow
Subscribe Now